全球愛滋病毒/愛滋病診斷市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計愛滋病毒/愛滋病診斷市場將從 2025 年的 57.8 億美元成長到 2034 年的 141.2 億美元，2026 年至 2034 年的複合年成長率為 10.44%。

由於公眾意識的提高、早期檢測項目的開展以及全球衛生舉措的推進，全球愛滋病毒/愛滋病診斷市場正穩步擴張。愛滋病毒診斷在控制感染傳播方面發揮著至關重要的作用，它能夠實現早期診斷和適當治療。各國政府和國際組織正大力投資於篩檢宣傳活動和檢查室基礎設施建設，以提高檢測服務的可近性。

成長要素包括檢測項目的增加、快速診斷試劑盒的廣泛普及以及檢測技術的進步。尤其是在發展中地區，就地檢驗和自測檢測套組的引入顯著提高了檢測的可及性。此外，更精準、更快速的診斷工具的開發正在提高檢出率，並支持改進患者管理策略。

未來幾年，由於全球持續努力消除愛滋病毒/愛滋病這一公共衛生威脅，市場預計將持續成長。分子診斷技術的進步和數位健康技術的融合將提高效率和監測水準。非洲和亞太地區對檢測的需求旺盛，預計市場將實現強勁成長，而已開發地區將專注於發展先進的自動化診斷系統。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球愛滋病毒/愛滋病診斷市場：依產品類型分類

• 市場分析、洞察與預測
• 裝置
• 試劑盒和試劑
• 其他

第5章 全球愛滋病毒/愛滋病診斷市場：依檢測類型分類

• 市場分析、洞察與預測
• 核酸檢測
• 快速檢測（POC​​）
• ELISA
• 其他

第6章 全球愛滋病毒/愛滋病診斷市場：依最終用戶分類

• 市場分析、洞察與預測
• 私人考試機構
• 醫院
• 研究機構及其他
• 學術機構

第7章 全球愛滋病毒/愛滋病診斷市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Hologic Inc
  • Alere
  • Bio-Rad Laboratories
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • OraSure Technologies Inc
  • Siemens Healthineers
  • Chembio Diagnostic Systems

The HIV/AIDS Diagnostics Market size is expected to reach USD 14.12 Billion in 2034 from USD 5.78 Billion (2025) growing at a CAGR of 10.44% during 2026-2034.

The Global HIV/AIDS Diagnostics market is expanding steadily due to increased awareness, early detection programs, and global health initiatives. HIV diagnostics play a crucial role in controlling the spread of infection by enabling early diagnosis and timely treatment. Governments and international organizations are investing heavily in screening campaigns and laboratory infrastructure to improve access to testing services.

Major growth drivers include the rising number of testing programs, availability of rapid diagnostic kits, and improvements in laboratory technologies. Point-of-care testing and self-testing kits have significantly increased accessibility, especially in developing regions. In addition, ongoing research for more accurate and faster diagnostic tools is enhancing detection rates and supporting better patient management strategies.

In the coming years, the market is expected to grow with continuous global efforts to eliminate HIV/AIDS as a public health threat. Technological advancements in molecular diagnostics and digital health integration will improve efficiency and monitoring. Africa and Asia-Pacific are expected to witness strong growth due to high testing demand, while developed regions focus on advanced and automated diagnostic systems.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Instruments
• Kits And Reagents
• Others

By Test Type

• Nucleic Acid Tests
• Rapid Tests (POC)
• ELISA
• Others

By End-user

• Private Diagnostics Laboratories
• Hospitals
• Research Institutes & Others
• Academic

COMPANIES PROFILED

• Hologic Inc, Alere, BioRad Laboratories, Abbott Laboratories, F HoffmannLa Roche Ltd, OraSure Technologies Inc, Siemens Healthineers, Chembio Diagnostic Systems
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HIV/AIDS DIAGNOSTICS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Kits And Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HIV/AIDS DIAGNOSTICS MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Test Type
• 5.2. Nucleic Acid Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Rapid Tests (POC) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. ELISA Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HIV/AIDS DIAGNOSTICS MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Private Diagnostics Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Research Institutes & Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Academic Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HIV/AIDS DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Test Type
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Test Type
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Test Type
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Test Type
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Test Type
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HIV/AIDS DIAGNOSTICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Hologic Inc
  • 9.2.2 Alere
  • 9.2.3 Bio-Rad Laboratories
  • 9.2.4 Abbott Laboratories
  • 9.2.5 F. Hoffmann-La Roche Ltd
  • 9.2.6 OraSure Technologies Inc
  • 9.2.7 Siemens Healthineers
  • 9.2.8 Chembio Diagnostic Systems